期刊文献+

术中放疗对保乳患者伤口引流液内GRO-1、VEGF的影响 被引量:2

Quantitative Analysis of GRO-1 and VEGF in the Wound Fluid of Patients after Breast-conserving Surgery and Intraoperative Radiotherapy
下载PDF
导出
摘要 目的研究早期乳腺癌保乳手术术中电子射线照射,对保乳患者伤口引流液内GRO-1和VEGF的影响。方法采取随机方法,将60例保乳手术患者分为对照组和试验组,每组30例,对照组患者单纯行保乳手术,试验组患者行保乳手术并术中辅以电子射线照射。收集两组患者术后24h伤口引流液。应用ELISA方法,检测引流液内GRO-1和VEGF含量。结果对照组患者引流液内GRO-1和VEGF的含量分别为(50.08±14.09)pmol/l和(427.16±20.18)ng/l,两者在表达上呈正相关性(γ=0.817,P<0.01);实验组患者引流液内GRO-1和VEGF的含量分别为(15.64±2.80)pmol/l和(206.55±6.34)ng/l,两者在表达上呈正相关性(γ=0.449,P<0.05)。与对照组比较,试验组GRO-1和VEGF含量均明显下降(P<0.01)。结论术中电子射线照射明显降低保乳手术患者伤口引流液内GRO-1和VEGF的含量,并且两者表达呈正相关性。 Objective To investigate the effects of growth-regulated oncogene-1 ( GRO-1 ) and vascular endothelial growth factor(VEGF) in the wound fluid of breast -conserving surgery patients by intraoperative radiotherapy with electrons during breast-conserving surgery of early breast cancer. Methods 60 breast-conserving surgery patients were randomly divided into control group and trial group. Control group contained 30 patients who received single breast-conserving surgery. Trila group contained the renmain 30 patients who received breast-conserving surgery and ELIOT. All wound fluid was then collected. The levels of GRO-1 and VEGF in every patient were determined by ELISA. Results The levels of GRO-1 and VEGF in control group were respectively (50.08 ± 14.09 )pmol/1 and (427.16± 20. 18 )ng/1, and the expression of GRO-1 and VEGF was positive correlated( X^2 =0. 817 ,P 〈0.01 ). The levels of GRO-1 and VEGF in trial group were respectively ( 15.64 ±2.80) pmol/1 and (206.55 ±6.34)ng/1,and the expression of GRO-1 and VEGF was positive correlated(γ =0. 449,P 〈0.05). Conclusion Intraopera- tive radiotherapy with electrons could obviously degrade the levels of GRO-I and VEGF in the wound fluid of breast-conserving surgery patients, and the expression of GRO-1 and VEGF was positive correlated.
出处 《实用癌症杂志》 2010年第2期129-132,共4页 The Practical Journal of Cancer
关键词 乳腺癌 伤口引流液 生长相关性癌基因-1 血管内皮生长因子 Breast cancer Wound fluid Growth-regulated oneogene-1 ( GRO-1 ) Vascular endothelial growth factor (VEGF)
  • 相关文献

参考文献13

  • 1Verenesi U, Luini A, DelVecchio M, et al. radiotherapy after breast-preserving surgery in women with localized cancer of the breast[J]. N Engl Med, 1993,328:1587.
  • 2Julien JP, Bijker N, Fentiman IS, et al. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ:first results of the EORTC randomised phase Ⅲ trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group [J]. Lancet, 2000,355 (9203) :528.
  • 3Barbara B ,Jayant S, Belletti B, et al. Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding[J]. Clin Cancer Res,2008,14 (5) : 1025.
  • 4Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1889[J]. Cancer Metastasis Rev, 1989 , 8(2) :98.
  • 5Fidler IJ. The pathogenesis of cancer metastasis : the seed and soil hypothesis revisited [J]. Nat Rev Cancer, 2003,3(6) :453.
  • 6Vaidya JS, Baum M, Tobias JS, et al. Targeted intra-operative radiotherapy ( Targit ) : an innovative method of treatment for early breast cancer[J]. Ann Oncol,2001,12 ( 8 ) : 1075.
  • 7Veronesi U, Orecchia R, Luini A, et al. Full dose intraoperative radiotherapy with electrons (ELIOT) during breast conserving surgery-experience with 1246 cases [J]. Ecancermedicalscience, 2008,2:65.
  • 8Folkman J. What is the evidence that tumor are angiogenes is dependent?[J]. Natl Cancer Inst, 1990,82 ( 1 ) :4.
  • 9Haghnegahdar H, Du J, Wang D, et al. The tumorigenic and angiogenic effects of MGsA/GRO proteins in melanoma [J].J Leukoc Biol,2000,67( 1 ) :53.
  • 10Suzuki H, Mori M, Seto K, et al. Rat CXC ehemokine GRO/CINC-1 paradoxically stimulates the growth of gastric epi- thelial cells[J]. Aliment Pharmaco Ther, 2000, 14 ( Suppl1 ) :94.

二级参考文献11

  • 1KITAMURA K, YAMAGUCHI T, TANIGUCHI H ,et al. Analysis of lymph node metastasis in early gastric cancer: rationale of limitated surgery[J]. J Surg Oncol, 1997,64( 1 ):42-47.
  • 2KAIPAINEN A,KORHOREN J,TAIPALE J,et al. Expression of the fms-like tyrosine kinase FLT-4 gene becomes restricted to endothelium of lymphatic vessels during development[J]. Proc Natl Acad Sci USA, 1995,92(8) : 3566-3570.
  • 3STEVEN A S, CAROL C, MEGEN E B, et al. VEGF-D promotes the metastasis spread of tumor cells via the lymphatics[J]. Natl Med ,2001,7(2) : 186-191.
  • 4BANERJI S,NI I,WANG S X,et al. LYVE-1, a new homologue of the CD44 glycoprotein,is a lymph-specific receptor for hyaluronan[J]. J Cell Biol, 1999,144(4) : 789-801.
  • 5KINOSHITA J,KITAMURA K,KABASHIMA A,et al. Clinical significance of vascular endothelial growth factor C (VEGF-C) in breast cancer[J]. Breast Cancer Res Treat, 2001,66 (2) : 159-164.
  • 6WANG J F, GANJU R K, LIU Z Y,et al. Signal transduction in human hematopoietic cells by vascular endothelial growth factor related protein, a novel ligand for the FLT4 receptor [J].Blood, 1997,90(9) : 3507-3515.
  • 7DUMONT DJ ,JUSSILA L, TAIPALE J ,et al. Cardiovascular failure in mouse embryos deficient in VEGF receptor 3[J]. Science, 1998,282(5390):946-949.
  • 8ONOGAWA S, KITADAI Y, TANAKA S, et al. Expression of VEGF-C and VEGF-D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma[J]. Cancer Sci, 2004,95 (1) : 32-39.
  • 9TSURUSAKI T,KANDA S,SAKAI H,et al. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis[J]. Br J Cancer,1999,80(1-2):309-313.
  • 10BONO P,WASENIUS VM, HEIKKILA P,et al. High LYVE-1-positive lymphatic vessel number are associated with poor outcome in breast cancer [J]. Clin Cancer Res, 2004, 10(21):7144-7149.

共引文献17

同被引文献26

  • 1郭涛,孙顺昌,郭作文,许彬,吕建敏.乳腺癌保乳手术加术中放疗40例临床分析[J].临床肿瘤学杂志,2006,11(2):139-141. 被引量:12
  • 2Reitsamer R,Peintinger F,Kopp M,et al.Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation:a sequential intervention study[J].Strahlenther Onkol,2004,180(1):38-44.
  • 3Veronesi U,Orecchia R,Luini A,et al,Full-dose intraoperative radiotherapy with electrons during breast conserving surgery:experience with 590 cases[J].Ann Surg,2005,242(1):101-106.
  • 4Veronesi U,Orecchia R,Luini A,et al.Intraoperative radiotherapy during breast conserving surgery:a study on 1 822 cases treated with electrons[J].Breast Cancer Res Treat,2010,124(1):141-151.
  • 5Arthur D W,Vicini F A,Kuske R R,et al.Accelerated partial breast irradiation:an updated report from the American Brachytherapy Society[J].Brachytherapy,2003,2:124-130.
  • 6Jacobson JA,Danforth DN,Cowan KH,et al.Ten year results of a comparison of conservation with mastectomy in the treatment of stage Ⅰ and Ⅱ breast cancer[J].N Engl J Med,1995,332(14):907-911.
  • 7Fisher B,Anderson S,Bryant J,et al.Twenty-year follow-up of a randomized trial comparing total mastectomy,lumpectomy,and lumpectomy plus irradiation for the treatment of invasive breast eaneer[J]N Engl J Med,2002,347(16):1233-1241.
  • 8Veronesi U,Cascinelli N,Mariani L,et al.Twenty year follow-up of a randonfized study comparing breast conserving surgery with radical mastectomy for early breast cancer[J].N Engl J Med,2002,347:1227-1232.
  • 9Salvatore,Mussari.Full-dose intraoperative radiotherapy with electrons in breast cancer[J].Strahlentherapie and Onkologie,2006,182(5):589.
  • 10James B,Wayne B,Anne R,et al.Relationship between in vitro chromosomal radiosensitivity of peripherial blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer[J].Radiat Oncol,2000,55(2):179.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部